PALLADYNE AI CORP (PDYN)

US80359A2050 - Common Stock

13.1053  +5.82 (+79.77%)

Fundamental Rating

3

Overall PDYN gets a fundamental rating of 3 out of 10. We evaluated PDYN against 132 industry peers in the Machinery industry. While PDYN has a great health rating, there are worries on its profitability. PDYN is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

PDYN had negative earnings in the past year.
PDYN had a negative operating cash flow in the past year.

1.2 Ratios

PDYN has a Return On Assets of -144.88%. This is amonst the worse of the industry: PDYN underperforms 95.38% of its industry peers.
With a Return On Equity value of -239.63%, PDYN is not doing good in the industry: 92.31% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -144.88%
ROE -239.63%
ROIC N/A
ROA(3y)-106.53%
ROA(5y)N/A
ROE(3y)-143.15%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

PDYN has a Gross Margin of 48.22%. This is amongst the best in the industry. PDYN outperforms 91.54% of its industry peers.
The Profit Margin and Operating Margin are not available for PDYN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 48.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

PDYN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, PDYN has more shares outstanding
PDYN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

PDYN has an Altman-Z score of -9.49. This is a bad value and indicates that PDYN is not financially healthy and even has some risk of bankruptcy.
PDYN's Altman-Z score of -9.49 is on the low side compared to the rest of the industry. PDYN is outperformed by 91.54% of its industry peers.
There is no outstanding debt for PDYN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -9.49
ROIC/WACCN/A
WACC9.23%

2.3 Liquidity

A Current Ratio of 5.02 indicates that PDYN has no problem at all paying its short term obligations.
With an excellent Current ratio value of 5.02, PDYN belongs to the best of the industry, outperforming 90.77% of the companies in the same industry.
PDYN has a Quick Ratio of 5.02. This indicates that PDYN is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 5.02, PDYN belongs to the best of the industry, outperforming 94.62% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.02
Quick Ratio 5.02

4

3. Growth

3.1 Past

PDYN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.78%, which is quite impressive.
Looking at the last year, PDYN shows a very negative growth in Revenue. The Revenue has decreased by -57.81% in the last year.
EPS 1Y (TTM)29.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.96%
Revenue 1Y (TTM)-57.81%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-52.33%

3.2 Future

PDYN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.00% yearly.
Based on estimates for the next years, PDYN will show a very strong growth in Revenue. The Revenue will grow by 153.11% on average per year.
EPS Next Y68.01%
EPS Next 2Y34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-6.25%
Revenue Next 2Y153.11%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

1

4. Valuation

4.1 Price/Earnings Ratio

PDYN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PDYN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as PDYN's earnings are expected to grow with 34.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for PDYN!.
Industry RankSector Rank
Dividend Yield N/A

PALLADYNE AI CORP

NASDAQ:PDYN (12/27/2024, 12:52:10 PM)

13.1053

+5.82 (+79.77%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)11-12 2024-11-12/bmo
Earnings (Next)N/A N/A
Inst Owners11.18%
Inst Owner ChangeN/A
Ins Owners42.24%
Ins Owner Change-0.14%
Market Cap394.60M
Analysts43.33
Price TargetN/A
Short Float %14.12%
Short Ratio0.43
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 50.78
P/FCF N/A
P/OCF N/A
P/B 16.85
P/tB 16.85
EV/EBITDA N/A
EPS(TTM)-2.16
EYN/A
EPS(NY)-0.57
Fwd EYN/A
FCF(TTM)-1.13
FCFYN/A
OCF(TTM)-1.13
OCFYN/A
SpS0.26
BVpS0.78
TBVpS0.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -144.88%
ROE -239.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 48.22%
FCFM N/A
ROA(3y)-106.53%
ROA(5y)N/A
ROE(3y)-143.15%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.68%
Cap/Sales 0.44%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.02
Quick Ratio 5.02
Altman-Z -9.49
F-Score5
WACC9.23%
ROIC/WACCN/A
Cap/Depr(3y)314.14%
Cap/Depr(5y)N/A
Cap/Sales(3y)38.46%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75.96%
EPS Next Y68.01%
EPS Next 2Y34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-57.81%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-52.33%
Revenue Next Year-6.25%
Revenue Next 2Y153.11%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year70.06%
EBIT Next 3YN/A
EBIT Next 5Y36.66%
FCF growth 1Y-15.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-17.17%
OCF growth 3YN/A
OCF growth 5YN/A